On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Tango Therapeutics (United States)

InstitutionResearch output, impact & collaborations

Tango Therapeutics (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Tango Therapeutics (United States)?

ScholarIQrecord summary

Tango Therapeutics (United States) is a research organisation in Cambridge, United States. OpenAlex records 144 works and 12,212 citations for it. 2 researchers list it as their most recent affiliation.

How many works does Tango Therapeutics (United States) have?

ScholarIQindexed works

Tango Therapeutics (United States) has 144 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Tango Therapeutics (United States) →

How many citations does Tango Therapeutics (United States) have?

ScholarIQcitation count

Tango Therapeutics (United States) has 12,212 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Tango Therapeutics (United States) →

How many researchers are at Tango Therapeutics (United States)?

ScholarIQresearcher count

Tango Therapeutics (United States) has 2 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Tango Therapeutics (United States)?

ScholarIQavg h-index

Tango Therapeutics (United States) has an average h-index of 39.5 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Tango Therapeutics (United States)?

ScholarIQror

The ROR for Tango Therapeutics (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Tango Therapeutics (United States)?

ScholarIQopenalex

The OpenAlex for Tango Therapeutics (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Tango Therapeutics (United States)?

ScholarIQtop researchers by citations

Samuel R. Meier · PARP inhibition in cancer therapy

212 works24,406 citations

Barbara L. Weber · Cancer Genomics and Diagnostics

210 works16,659 citations

What are the most-cited papers on Tango Therapeutics (United States)?

ScholarIQmost cited works

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway

Nature. 20128,591 Citations

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.

Richard L. Wahl, Kenneth Zasadny, Mark A. Helvie, Gary D. Hutchins, Barbara L. Weber, Robert Cody

Journal of Clinical Oncology. 1993612 Citations

Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate

Abhishek A. Chakraborty, Tuomas Laukka, Matti Myllykoski, Alison E. Ringel, Matthew A. Booker, Michael Tolstorukov, Yuzhong Jeff Meng, Samuel R. Meier, Rebecca B. Jennings, Amanda L. Creech, Zachary T. Herbert, Samuel K. McBrayer, Benjamin A. Olenchock, Jacob D. Jaffe, Marcia C. Haigis, Rameen Beroukhim, Sabina Signoretti, Peppi Koivunen, William G. Kaelin

Science. 2019440 CitationsOPEN ACCESS

How much of the research on Tango Therapeutics (United States) is open access?

ScholarIQopen access share

33%OPEN ACCESS

Gold

Green

33%

Hybrid

Bronze

Closed

67%